Dihydroxyacetone in a new formulation--a powerful therapeutic option in vitiligo

Dermatology. 2001;203(3):241-3. doi: 10.1159/000051757.

Abstract

Background: Most treatment protocols for vitiligo require a long treatment duration and usually do not result in complete repigmentation. Therefore, cosmetically acceptable and easily to handle alternatives are warranted.

Objective: To evaluate the properties of dihydroxyacetone (DHA) in a new formulation for the treatment of vitiligo on exposed areas.

Methods: We treated 10 patients suffering from vitiligo affecting the face and/or hands with a newly introduced, commercially available self-bronzing cream containing DHA 5%. DHA was applied every second day.

Results: The characteristic pigmentation showed very satisfactory cosmetic results in 8 out of 10 patients after 2 weeks of treatment.

Conclusion: The new DHA formulation is a practical and well-accepted treatment modality.

MeSH terms

  • Cosmetics / therapeutic use*
  • Dihydroxyacetone / therapeutic use*
  • Dosage Forms
  • Humans
  • Vitiligo / therapy*

Substances

  • Cosmetics
  • Dosage Forms
  • Dihydroxyacetone